Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal. - Wikidata - awgldk - TriplyDB

Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.

Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.

http://www.wikidata.org/entity/Q42595918

about

Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?Stem Cells and Their Mediators - Next Generation Therapy for Bronchopulmonary Dysplasia Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells Mesenchymal stem cells: immune evasive, not immune privileged Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation.Diverging Concepts and Novel Perspectives in Regenerative Medicine.Multipotential stromal cell abundance in cellular bone allograft: comparison with fresh age-matched iliac crest bone and bone marrow aspirate.Potential advantages of acute kidney injury management by mesenchymal stem cells.Concise review: different mesenchymal stromal/stem cell populations reside in the adult kidney Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice.In quest of optimal drug-supported and targeted bone regeneration in the cranio facial area: a review of techniques and methods.In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice Establishing a Quality Control System for Stem Cell-Based Medicinal Products in China Temporal Analyses of the Response of Intervertebral Disc Cells and Mesenchymal Stem Cells to Nutrient Deprivation.CD11b+ and Sca-1+ Cells Exert the Main Beneficial Effects of Systemically Administered Bone Marrow-Derived Mononuclear Cells in a Murine Model of Mixed Th2/Th17 Allergic Airway Inflammation.Characterisation of synovial fluid and infrapatellar fat pad derived mesenchymal stromal cells: The influence of tissue source and inflammatory stimulus.Role of Human Corneal Stroma-Derived Mesenchymal-Like Stem Cells in Corneal Immunity and Wound Healing.Clinical-scale expansion of mesenchymal stromal cells: a large banking experience.Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application Utility of a Mouse Model of Osteoarthritis to Demonstrate Cartilage Protection by IFNγ-Primed Equine Mesenchymal Stem Cells Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro.Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton's jelly and bone marrow Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use.Adult human mesenchymal stromal cells and the treatment of graft versus host disease.Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function Establishing criteria for human mesenchymal stem cell potency.Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity.The regulatory sciences for stem cell-based medicinal products.

P2860

Q24188275-C340F806-C7DF-4E21-9B60-C23676897614 Q26746104-C199C5F3-7BCB-4B7C-9C84-63FEFA3197D1 Q26766574-EE965961-4FE9-4AE8-890F-A5B543A1C2BD Q26797261-9197EC95-6261-48E8-9680-7DEE5418A617 Q26798278-573DFD61-EFEF-416E-AEB8-8075FAD455AD Q26822005-5F06C18B-A01E-413B-93D6-3C261A3F8B0B Q27003371-1A3276C2-69AF-4DB4-AD11-16080D1481A1 Q28079089-05207526-2171-48D6-B1E8-5D4B7D70DB40 Q28081921-62284BE7-2B04-4A8E-B48A-1B8958BECB89 Q30488740-00D6639E-2CE9-4665-B495-97D27137422C Q33637202-00263D8F-AE1E-44FB-8C9D-6E1CE360C1A9 Q33755185-3E6BD7FF-7A1C-4FA8-BF33-88BD3C0496D5 Q33830872-6EA0665C-53F2-4788-9FFB-D30858B961D3 Q34259151-EE17D60C-4D44-4C26-9795-C1B964923D3A Q34601952-FCBE3DFB-AEF0-449B-8883-4034192468BC Q34753440-12D08459-71C6-4630-8FF3-818FB23A6A2C Q34979619-708B0B18-EA7D-4B2B-A103-D17FFCE7A40B Q35007600-4510EFBE-4713-4D41-AE79-E622CE5DD000 Q35344810-68BB43E6-0F6E-40FE-AEDF-997E34D0A744 Q35538204-EB9F621B-5196-4892-8F18-AC4E05F4786D Q35665325-8202DBD6-6417-45A1-9E08-AEDEA55C7F30 Q35874102-6117D28B-D47E-439C-B389-02C253C9E71C Q36067836-7C49E198-3DD5-4DC1-B014-DCDBD7B60E8E Q36212633-89FD5C73-858B-4C8D-BCBE-34C704A966F9 Q36385946-D08F9179-63D0-4DD5-84D8-F7192C035154 Q36610572-FFF94484-33E4-4A9B-94B0-9ECB8D0958B6 Q36703006-84056EC8-3272-4E91-AD49-CCDCB77CCF41 Q36793110-227CC606-98A8-495C-9D99-DE1EBAC23E03 Q36915887-0F41C5AB-BECB-4288-A172-2411A2C55C15 Q36923358-AD09E368-594A-42B1-B893-BFA9A2BB0818 Q36998274-FC7594B2-128B-44EA-9F9D-F5A76E97FEE6 Q37284607-DCD28BED-8752-47BE-9C59-8DA5B9C7E969 Q37372319-BAA30E38-7158-4620-B828-AC8BD29F9936 Q37393107-8EB96267-2653-47A6-B858-0F51F77D6559 Q37602625-5765A4A3-DA98-44DC-B14F-57E70EDBAC27 Q37622055-C1835157-CEC2-46B6-ABE7-266D582249BD Q37637831-9EFF4798-3423-4BC3-9D42-4752F8A1452F Q37718020-7A32CF9C-3C7E-41BE-BFB6-457A8CAE2053 Q37737100-ADF4E151-E1EF-4C4C-BCC3-8236ED780329 Q38204699-647FF402-6BC2-41C6-A44E-18BD51CD80C6

P2860

Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.

http://www.wikidata.org/entity/Q42595918

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Immunological characterization ...... erapy (ISCT) working proposal.

@en

Immunological characterization ...... l Society for Cellular Therapy

@nl

type

label

Immunological characterization ...... erapy (ISCT) working proposal.

@en

Immunological characterization ...... l Society for Cellular Therapy

@nl

prefLabel

Immunological characterization ...... erapy (ISCT) working proposal.

@en

Immunological characterization ...... l Society for Cellular Therapy

@nl

P1433

Q42595918-402441FA-6B6B-4FF7-97C0-ECB3BC0DB1FB

P1476

Q42595918-A1D13BFF-6464-45AD-9B9A-54C168E82BEE

P2093

Q42595918-0BC4041C-47B8-4617-AB7F-F4865E185FC6

Q42595918-260D23FC-31BE-45D2-8372-D380B61F5657

Q42595918-3DD34EE0-0931-4586-B73C-D929DDB0E1C7

Q42595918-9B3AEC5A-38B7-4726-A800-E13E85CD2238

Q42595918-DF568068-96C0-49D5-9128-0A2160D3AAFF

Q42595918-E8BB5982-120D-4A74-8413-CB2757ED528A

P304

Q42595918-FB88C2A5-8C71-459B-98AC-6FFDF06C4D50

P31

Q42595918-F5E65002-EEAA-480E-9CA4-CAC93AD94457

P356

Q42595918-60A6A037-CBC9-4BDA-A1F5-DDE0994C427C

P433

Q42595918-D5AD578C-8A55-4B68-B1EA-44AFB2696FA4

P478

Q42595918-50FC569F-BA6A-449B-AC72-7EB72A9DF3A8

P577

Q42595918-8752ED84-EEF7-410D-B4C7-5FA9FFE0962D

P5875

Q42595918-04A23CFC-FF5D-4874-A991-FC398E4DDDD5

P698

Q42595918-97CE6E13-9F42-4EC1-B4FD-AF04A44EFA22

P921

Q42595918-255616F1-F297-437F-9F82-59DD69663149

P356

J.JCYT.2013.02.010

P1433

P1476

Immunological characterization ...... erapy (ISCT) working proposal.

@en

P2093

Jacques Galipeau

http://www.w3.org/2001/XMLSchema#string

Karin Tarte

http://www.w3.org/2001/XMLSchema#string

Luc Sensebe

http://www.w3.org/2001/XMLSchema#string

MSC Committee of the International Society for Cellular Therapy (ISCT)

http://www.w3.org/2001/XMLSchema#string

Mauro Krampera

http://www.w3.org/2001/XMLSchema#string

Yufang Shi

http://www.w3.org/2001/XMLSchema#string

P304

1054-1061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCYT.2013.02.010

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271563657

http://www.w3.org/2001/XMLSchema#string

P698

23602578

http://www.w3.org/2001/XMLSchema#string

P921